Tissue Microarray Market Information: By Procedure (Immunohistochemistry, Fluorescent In-Situ Hybridization), By Technology (DNA Microarray, Next-Generation Sequencing), By Application (Oncology, Gene Expression Profiling, and others), and By End User (Pharmaceutical And Biotechnological Companies) – Global Forecast till 2023
The market of tissue microarray treatment is growing extensively. It is a practical and effective tool for high-throughput molecular analysis of tissues that is helping to identify new diagnostic and prognostic markers and targets in human cancers, and has a range of potential applications in basic research, prognostic oncology and drug discovery. The growing need of targeted treatments for various chronic diseases like cancer, genetic diseases, among others has boosted the growth of the market.
The Global Tissue Microarray Market is expected to grow at a CAGR of 10.88% during the forecast period 2017-2023.
According to a recent study report published by the Market Research Future analysts, the global tissue microarray market is growing at a double digit growth rate; mainly due to the increasing application of tissue microarray in drug discovery and oncology, automated analysis of results and influence of technology are some of the major factors that fosters the growth of global tissue microarray market. Moreover, wide application of tissue microarray in pathology is another factor which is impelling the growth of tissue microarray market.
On the other hand tissue microarray may not be fruitful for heterogeneous cancers and the sample may not represent the entire tumour which may hamper the market growth.
Global Tissue Microarray Market – Competitive Analysis
Abcam plc (U.K), Externautics (Italy), Asterand Bioscience (U.S), Auria Biopankki (Finland), US Biomax Inc. (U.S), Protein Biotechnologies Inc. (U.S), OriGene Technologies Inc (U.S), Novus Biologicals, LLC (U.S) and OriGene Technologies Inc.(U.S) are some of the prominent players at the forefront of competition in the global tissue microarray market and are profiled in MRFR Analysis.
The market of tissue microarray consist of number of players that are involved in the development of the products as well as tests. The companies have involved actively in the development of the advanced products and also some have adopted the strategies of the mergers, acquisitions, and collaborations with other players in order to enhance their business.
Get a Brochure of This Report @ https://www.marketresearchfuture.com/sample_request/1213 .
In December 2016, Agilent Technologies announced the acquisition of Multiplicom N.V., a Leading European Diagnostics Company. On this acquisition Herman Verrelst, vice president said “The acquisition of Multiplicom significantly strengthens our presence in the genomics market.
In November 2013, Agilent technologies launched the enhance version SureDesign software enabling clinical researchers to design customized CGH , ChIP-on-chip and DNA methylation microarrays for molecular cytogenomics applications and other applications.
In July 2016, Applied Microarrays announce a strategic partnership with SCIENION to deliver next generation medical devices. NGS could be used to provide comprehensive deep-sequence analysis of either genomic DNA to identify mutations, or RNA.
In November 2015, Abcam plc acquired AxioMx in order to maintain its leadership in the market. Abcam, a provider of monoclonal recombinant antibodies is a global life science company manufacturing antibodies, agonists, antagonists, activators, and inhibitors and proteins and peptides
In December 2009, Externautics signed an agreement with HansaBioMed for co-development of new tumor markers. Externautics is an oncology biomaker discovery company. The company works on two technologies namely Yomics library and tissue microarray.
The global tissue microarray market is segmented on the basis of procedure, technology, application, and end user.
On the basis procedure, it is segmented into immunohistochemistry, fluorescent in-situ hybridization, and frozen tissue array.
On the basis of technology, it is segmented into DNA microarray, polymerase chain reaction, next-generation sequencing, northern blotting, and western blotting.
On the basis of application, it is segmented into oncology, gene expression profiling, SNP detection, double-stranded B-DNA microarrays, and comparative genomic hybridization, and sequencing bioinformatics.
Grab Attractive Discount @ https://www.marketresearchfuture.com/check-discount/1213 .
On the basis of end user, it is segmented into pharmaceutical and biotechnological companies, research organization, and others.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312